Clinical Research

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | PR Newswire | 1/20/2020

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape News provided by Jan 20, 2020, 14:00 ET Share this article DUBLIN , Jan. 20, 2020 /PRNewswire/ – The “Global Contract Research Organization (CRO) Market, Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering. Owing to a constantly changing pharmaceutical landscape, the industry is expected …

New Collaboration Yields Personalized Medical Guidelines and Educational Platform for Physicians | PRWeb | 1/20/2020

… by focusing on patient-centered care and a focus on customer satisfaction. SMC remains dedicated to improving health and enhancing the quality of life through the provision of state-of-the-art patient care, clinical research and education. During the past 20 years, SMC has won first place in the National Customer Satisfaction Index (NCSI) 14 times, first place in the Korean Customer Satisfaction Index (KCSI) 16 times, first place …

Follow Clinical Research:    

Greenphire Expands ConneX Global Travel Solution to Further Support Clinical Trial Participation and Retention Worldwide | PR Newswire | 1/20/2020

… becomes more personalized, trials often require highly-specific patient populations, and travel is often required. Sometimes, potential patients are excluded simply because they cannot make it to the site’s physical location,” said Society for Clinical Research Sites ( SCRS ) President, Casey Orvin . “It is critical that sites are able to access a wider patient pool, and have tools they can use to ease this concern. Traveling to participate in a trial …

Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025 - ResearchAndMarkets.com | Business Wire | 1/20/2020

DUBLIN- The “Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025” report has been added to ResearchAndMarkets.com’s offering. The development of cancer organoids has transformed the widespread adoption of the traditional 2D cell lines in the research community. The technology of cancer organoids holds significant potential to study a variety of areas such as cancer disease pathology, cancer biology, precision medicine, drug development, drug testing and drug efficacy …

Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes | Globe Newswire | 1/20/2020

… the University of Zurich, University of Cambridge and University of Basel conducted the 352-patient study, results of which have been published today in Nature 1 . The Hyperion Imaging System is revolutionizing translational and clinical research by providing unprecedented visualization of complex cellular phenotypes and their relationships in the context of cancer, immuno-oncology and immune-mediated diseases. Using the dual capability to perform both mass cytometry and IMC, researchers …

Postnatal care following hypertensive disorders of pregnancy: a qualitative study of views and experiences of primary and secondary care clinicians | BMJ | 1/20/2020

Table 1 Study ID number and clinical background of participants The analysis generated four main themes: variation in knowledge and clinical practice; communication and education; provision of care; locus of responsibility for care, each with two to four subthemes, which are presented in the following sections. Variation in knowledge and clinical practice Clinicians’ lack of assessment and knowledge Clinicians were aware of the importance of identifying postnatal women with HDP …

MCRA Hires Reimbursement Strategy Director | 1/20/2020

Breaking News MCRA Hires Reimbursement Strategy Director The staffing helps expand MCRA’s medical technology market access expertise for both commercial and government payers. PR Newswire 01.20.20 MCRA LLC, is a clinical research organization (CRO) and advisory firm specializing in medical devices and biologics. Its integration of regulatory, clinical research, reimbursement, compliance, and quality assurance assists companies in bringing new technologies and products to the commercial market. MCRA is expanding its …

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making | 1/20/2020

Editor who approved publication: Dr Johnny Chen Peter C Taylor, 1 Neil Betteridge, 2 T Michelle Brown, 3 John Woolcott, 4 Alan J Kivitz, 5 Cristiano Zerbini, 6 Diane Whalley, 7 Oyebimpe Olayinka-Amao, 3 Connie Chen, 8 Palle Dahl, 9 Dario Ponce de Leon, 10 David Gruben, 11 Lara Fallon 12 1 Botnar Research Centre, University of Oxford, Oxford, UK; 2 Neil Betteridge Associates, London, UK; 3 Patient-Centered …

Govt Life Science Vaccine Project Manager Job – Rs. 1 Lakh pm Salary | 1/20/2020

… life sciences or biomedical sciences or pharmacy or Public Health OR MBBS/ BDS/ BHMS/ BAMS/ BPT OR Masters in Clinical Research. Essential experience : At least 4 years of demonstrated experience in the area of clinical research project management and/ or clinical operations and/ or clinical research monitoring, lab monitoring, vendor management and team management. GCP trained and experience of handling clinical trials will be preferred Desirable Qualification for Govt Job …

Ascentrik Research Pvt Ltd hiring for Clinical Research Associate_pune (exp) | 1/20/2020

Ascentrik Research Pvt Ltd hiring for Clinical Research Associate_pune (exp) Ascentrik Research Pvt Ltd hiring for Clinical Research Associate_pune (exp) GM January 20, 2020 Ascentrik Research Pvt Ltd hiring for Clinical Research Associate_pune (exp) Job description Clinical Research Associate We are looking for a Clinical Research Associate with at least 0.6-2 years of relevant experience. A highly organized person, with excellent coordination, communication and team management skills …

Work as Scientific Writer at Cactus | Ph.D, M.Pharm, M.Sc | 1/20/2020

PhD/MD (Pharmacology) OR PhD (Life Sciences) OR MBBS/MD • M.Pharm / M.Sc with a good understanding of clinical research and medical communication • Knowledge of clinical research and drug development • PhD in a subject area related to medicine • Excellent literature reviewing and evaluation capabilities • Publication experience, preferably as first author, in reputed journals • Clear, concise, scientific style of writing, with a high level of attention to detail and superior English-language …

Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) | 1/20/2020

… With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) Shelby D. Reed 1 ⇑ , Rury R. Holman 5 and Adrian F. Hernandez 1 , for the EXSCEL Study Group 1 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 2 Oxford Health Economic Research Centre, University of Oxford, Oxford, U.K. 3 AstraZeneca Research and Development, Gaithersburg, MD 4 AstraZeneca, Mölndal, Sweden 5 Diabetes Trials Unit …

Aspiring neurosurgeon mapping cancer-suppressing protein | 1/20/2020

Aspiring neurosurgeon mapping cancer-suppressing protein Schreyer Scholar Madison Evans looks to enter medical school with strong research portfolio Penn State Schreyer Scholar and biomedical engineering student Madison Evans has interned in neurosurgical clinical research at the Hospital of the University of Pennsylvania as well as a biotech company and a medical device company. Image: Jeff Rice Aspiring neurosurgeon mapping cancer-suppressing protein Jeff Rice January 20, 2020 UNIVERSITY PARK …

Newly published Avera study reveals new details about SIDS risks | 1/20/2020

… and drinking during pregnancy. The study, published Monday in eClinicalMedicine, found smoking cigarettes and drinking alcohol during pregnancy significantly increase the risk of sudden infant death syndrome, or SIDS. Dr. Amy Elliott, the Chief Clinical Research Officer of the Avera Center for Pediatric and Community Research in Sioux Falls, is the corresponding and co-first author of the study. She said while past studies have looked into the risk caused …

Issues and Events | 1/20/2020

The 67th annual American Diabetes Association Advanced Postgraduate Course will be held in San Francisco, CA, from 31 January to 2 February 2020. Join your colleagues and diabetes experts for presentations and discussions on cutting-edge clinical research in diabetes. The course will cover the latest clinical research translated into evidence-based treatment strategies to improve outcomes in your patients with diabetes. Discuss clinical cases with world-renowned faculty and …

Chief Medical Officer Job (NPS-128) - DaVita SOURCE - , CO | 1/20/2020

… building and maintaining relationships withNPS business leadership Leading clinical activities for NPS – inclusive of the NPS Physician Council, oversight of theclinical operations of NPS Practices (owned and affiliated), NPS quality programs and metrics,NPS clinical research activities, NPS clinical policies and other integrated kidney care initiatives Performance management and mentoring of NPS Physicians and Advanced Practitioners anddriving scalable operational and clinical performance Participation in development activities and practice acquisitions Participation …

Using artificial intelligence to detect hypoglycaemic events via wearable sensors | 1/20/2020

… circumstance, including sleeping.” “Our approach enable personalised tuning of detection algorithms and emphasize how hypoglycaemic events affect ECG in individuals. Basing on this information, clinicians can adapt the therapy to each individual. Clearly more clinical research is required to confirm these results in wider populations. This is why we are looking for partners.” The Latest Updates from Bing News & Google News Go deeper with Bing News on: Wearable sensors Wearable …

[R.E.A.D] Electronic Patient-Reported Outcome Measures An Implementation Handbook For Clinical Research [PDF Ebook] | 1/19/2020

Download [PDF] Electronic Patient-Reported Outcome Measures: An Implementation Handbook For Clinical Research Ebook Download at: https://ebookuniverse.club/?book=1720281106 Download Electronic Patient-Reported Outcome Measures: An Implementation Handbook For Clinical Research read ebook Online PDF EPUB KINDLE Electronic Patient-Reported Outcome Measures: An Implementation Handbook For Clinical Research pdf download Electronic Patient-Reported Outcome Measures: An Implementation Handbook For Clinical Research pdf Electronic Patient-Reported Outcome Measures: An Implementation …

P.D.F_EPUB Ethical Issues in Clinical Research A Practical Guide book ([Read]_online) #pdf #kindle #online | 1/19/2020

Read [PDF] Download Ethical Issues in Clinical Research A Practical Guide book Full Download [PDF] Ethical Issues in Clinical Research A Practical Guide book Full PDF Download [PDF] Ethical Issues in Clinical Research A Practical Guide book Full Kindle Download [PDF] Ethical Issues in Clinical Research A Practical Guide book Full Android Download [PDF] Ethical Issues in Clinical Research A Practical Guide book Full Full Ebook Download [PDF] Ethical Issues …

Gender and Adolescent Advisor - Uyo, Akwa Ibom | INIJOBHOUSE | 1/19/2020

The Center for Clinical Care and Clinical Research – An indigenous, non-profit organization registered in Nigeria in 2010 to promote best practices in health care delivery, medical training and research using locally adapted models of health systems strengthening. CCCRN implements projects through a team of experienced health and allied professionals that include clinicians, laboratorians, community workers and health information specialists. CCCRN has established footprints in 14 states of Nigeria with …

Digital Health

New Collaboration Yields Personalized Medical Guidelines and Educational Platform for Physicians | 1/21/2020

… physician and an Assistant Professor in the Department of Emergency Medicine at SMC. “SMC is on the cutting edge of digital health and medical innovation,” said Dr. Joongheum Park, Chairman and Head of Product at … through the provision of state-of-the-art patient care, clinical research and education. During the past 20 years, SMC has won first place in the National Customer Satisfaction Index (NCSI) 14 times, first place …

Regenerative Medicine

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | PR Newswire | 1/20/2020

… regenerative medicine).As a result of a higher R&D activity, there is higher reliance on outsourcing partners (e.g., CRO vendors) that support pharma and biotech participants with cost-effective and time-efficient drug development services. The global CRO industry is a highly fragmented and competitive market, with more than 1,000 participants globally. Europe is emerging as a key location for clinical research, with several small-to-mid segment niche …

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | Benzinga | 1/20/2020

… regenerative medicine). As a result of a higher R&D activity, there is higher reliance on outsourcing partners (e.g., CRO vendors) that support pharma and biotech participants with cost-effective and time-efficient drug development services. The global CRO industry is a highly fragmented and competitive market, with more than 1,000 participants globally. Europe is emerging as a key location for clinical research, with several small-to-mid segment niche …

Genomics

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research® | Globe Newswire | 1/17/2020

… global NIPT market is highly fragmented with the presence of key players, such as Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.) among others. Browse key industry insights: https://www.meticulousresearch.com/product/non-invasive-prenatal-testing …

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research® | Benzinga | 1/17/2020

… global NIPT market is highly fragmented with the presence of key players, such as Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.) among others. Browse key industry insights: https://www.meticulousresearch.com/product/non-invasive-prenatal-testing …

Clinical Collaboration

Generex Biotechnology Provides 2019 Year-End Summary & 2020 Plans | 1/17/2020

… As per our licensing agreement, Shenzhen is planning a global trial in China and in Europe using one of our clinical research sites that have previous experience conducting clinical trials with AE37. We look forward … research institutions, and additional announcements will be forthcoming regarding these clinical collaborations. In parallel with the reorganization of our corporate assets and operations, we made a concerted effort to fix our balance sheet in 2019 …

Clinical Information Systems

Healthcare Cloud Computing Market Hit USD 27.8 Billion by 2026: Grand View Research, Inc. | 1/17/2020

… Healthcare Cloud Computing Market https://www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market Further key findings from the study suggest: · Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted … and Sectra AB · Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected …

Revenue Cycle Management

Healthcare Cloud Computing Market Hit USD 27.8 Billion by 2026: Grand View Research, Inc. | 1/17/2020

… www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market Further key findings from the study suggest: · Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted for the largest revenue share … and Sectra AB · Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected …

Clinical Genomics

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research® | Globe Newswire | 1/17/2020

… Platform, Software), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Global Forecasts to 2025, read more: https://www.meticulousresearch.com/product/next-generationg-sequencing-market-5040/ Clinical Genomics Market by Test Type (Diagnostic, Genetic, Newborn Screening, Prenatal, Carrier Screening), Software, Method (Molecular, Chromosomal, Biochemical Tests), End User (Hospitals and Clinics) - Global Forecast to 2023, read more: https://www.meticulousresearch.com/product/clinical-genomics-market-forecast …

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research® | Benzinga | 1/17/2020

… Platform, Software), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Global Forecasts to 2025, read more: https://www.meticulousresearch.com/product/next-generationg-sequencing-market-5040/ Clinical Genomics Market by Test Type (Diagnostic, Genetic, Newborn Screening, Prenatal, Carrier Screening), Software, Method (Molecular, Chromosomal, Biochemical Tests), End User (Hospitals and Clinics) - Global Forecast to 2023, read more: https://www.meticulousresearch.com/product/clinical-genomics-market-forecast …

Biotechnology Innovation Organization

AMR Life Science Industry 2020 Report: Successes and Setbacks in Fighting Superbugs | 1/17/2020

… R&D. The Alliance warns that R&D investments are at concerning levels in the most costly later stages of clinical research. This contrasts with a promising biotech pre-clinical pipeline and new rapid infection … IFPMA [email protected] +41 22 338 32 00 Andrew Segerman Biotechnology Innovation Organization (BIO) [email protected] +1 202 747 1281 Jon Dobson AdvaMed [email protected] +1 202 434 7272 Permalink : https://www.aetoswire.com/news/amr-life …

Behavior Change Programs

Bon Secours Mercy Health invests in Lirio artificial intelligence platform | Healthcare IT News | 1/17/2020

… more than 1,000 care sites across seven U.S. states and in Ireland. Together, the two organizations will “co-develop new behavior change programs that target at-risk populations proactively and preventatively in ways that both … decisions and take healthy actions,” said Dr. Justin McGoldrick, chief clinical research and innovation officer at Bon Secours Mercy Health, in a statement …

Bon Secours Mercy Health and Lirio Announce Partnership and Investment | PR Newswire | 1/16/2020

clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health of the communities we serve.” Lirio and Bon Secours Mercy Health will co-develop new behavior change programs that influence health decision-making for those at risk for chronic diseases, such as diabetes and hypertension. These programs will eventually be marketed and sold to other …

Medical Research

CenExel Leads Industry in Psychiatric Studies at Atlanta Center for Medical Research | Markets Insider | Business Insider | 1/16/2020

SALT LAKE CITY , Jan. 16, 2020 /PRNewswire/ – CenExel Clinical Research recently strengthened its psychiatric team with the recruitment of Mark N. Lerman , MD, to serve as a principal investigator for phase I-IV studies at the Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence. ACMR is a well-recognized leader in clinical research and focuses primarily on studies involving central nervous system disorders. Dr. Lerman joins three …

Sectra

Healthcare Cloud Computing World Market Analyses; 2014-2019 & 2020-2026 | PR Newswire | 1/17/2020

Sectra AB. Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years. Key Topics Covered Chapter 1 Methodology & Scope Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Segment Outlook 2.3 Competitive Insights Chapter 3 Healthcare Cloud Computing Market Variables, Trends …

Partners Pursue FDA Clearance for Integrated Digital Pathology Solution | 1/15/2020

Partners Pursue FDA Clearance for Integrated Digital Pathology Solution 14, 2020 Sectra, Linköping, Sweden, and Leica Biosystems, Shelton, Conn, have collaborated to develop an integrated digital pathology solution that will address the needs of enterprise-level clinical customers such as academic medical centers, clinical research organizations, and large hospital networks. A premarket notification (510(k)) application for the combined solution has been submitted to FDA. “Leveraging Leica Biosystems’ existing 510 …

Line Health

Main Line Health’s Motivation Behind Investing In A New Internal Comms Platform | 1/17/2020

Main Line Health’s Motivation Behind Investing In A New Internal Comms Platform 2020-01-17 2020-01-17 /wp-content/uploads/2018/07/sc_logo_white_154x60.png SocialChorus https://www.socialchorus.com/wp-content/uploads/2020/01/bridget.jpg 200px 200px Share the … call LIMR, which is where a lot of really amazing clinical research takes places, and evolves to the bedside over time. Then, we have many physician practices across our region. Bridget: A very large complex …

Electrophysiology training in crisis | 11/8/2019

… make research grants available for all fellows who wish to spend an extra year in the basic lab or in clinical research, during which they can be absolved from clinical responsibilities. We need to systematize … Research in Wynnewood, Pennsylvania, Chairman Emeritus of Cardiology at Main Line Health and professor of medicine and clinical pharmacology at Jefferson Medical College in Philadelphia. He is also the editor of the Arrhythmia Disorders section …

SOPHiA Genetics

IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies | 1/16/2020

IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies Stocks News Feed CORALVILLE, Iowa–( BUSINESS WIRE )– Integrated DNA Technologies (IDT … analytics platform and advanced multimodal solutions, provide powerful solutions for clinical researchers. When bundling IDT’s reagents with the SOPHiA Platform, researchers will benefit from sophisticated analysis technology and the collective intelligence of the SOPHiA community …

IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies | Business Wire | 1/15/2020

CORALVILLE, Iowa- Integrated DNA Technologies (IDT) , a leading comprehensive genomics solutions provider, announced an expanded global partnership with SOPHiA GENETICS, a leader in Data-Driven Medicine. Together, the superior enrichment products of IDT combined with SOPHiA GENETICS’s universal analytics platform and advanced multimodal solutions, provide powerful solutions for clinical researchers. When bundling IDT’s reagents with the SOPHiA Platform, researchers will benefit from sophisticated analysis technology and the collective intelligence of …

AiCure

AiCure’s strategy of providing data for life sciences reinforced by record economic momentum | PR Newswire | 1/14/2020

NEW YORK AiCure , recognized as one of the world’s 100 most innovative artificial intelligence (AI) companies, announced significant 2019 company momentum, growing revenue by over 65% from the prior year. In September 2019 , AiCure announced … the top 20 global pharmaceutical companies Expanded global reach advancing clinical research across 16 new countries Initiated 17 new clinical trial programs across 13 therapeutic areas About AiCure AiCure is an AI and advanced data …

Four ways AI and machine learning will transform healthcare in 2020 | 1/3/2020

… consideration around how tools are implemented across various areas of healthcare, and for Mario Nacinovich, global head, communications & marketing at AiCure – which uses AI to see, hear and understand how patients respond to treatment – there … performing in real-time and how patients are responding in clinical research including medication adherence and their behaviour” Mario Nacinovich Overarchingly, though, he believes that deploying AI capabilities more effectively comes down to “ensuring that …

MedImmune

Contrasting Iovance Biotherapeutics (NASDAQ:IOVA) & Solid Biosciences (NASDAQ:SLDB) | 1/13/2020

… preclinical research studies; strategic alliance agreement with Roswell Park Cancer Institute to conduct a clinical research study of TIL therapy in bladder cancer; collaboration agreement with MedImmune to conduct clinical and preclinical research in immuno-oncology; preclinical research collaboration with the Ohio State University; and a preclinical research collaboration with Cellectis S.A. to investigate transcription activator-like effector nucleases. The company was formerly known as Lion Biotechnologies, Inc. and changed …

Iovance Biotherapeutics (NASDAQ:IOVA) versus Pharmacyte Biotech (NASDAQ:PMCB) Financial Comparison - Ticker Report | 1/7/2020

… preclinical research studies; strategic alliance agreement with Roswell Park Cancer Institute to conduct a clinical research study of TIL therapy in bladder cancer; collaboration agreement with MedImmune to conduct clinical and preclinical research in immuno-oncology; preclinical research collaboration with the Ohio State University; and a preclinical research collaboration with Cellectis S.A. to investigate transcription activator-like effector nucleases. The company was formerly known as Lion Biotechnologies, Inc. and changed …

Medable

Medable to Host Digital Trial Events at J.P. Morgan Healthcare Conference 2020 | Malvern Daily Record | 1/13/2020

Medable Inc ., the end-to-end platform for digitally enabled and data-driven clinical trials, today announced that Medable will host DCentralized, an evening at Hibernia Bank, featuring astute panelists discussing the state of decentralized … capture and real-time analytics that remove the complexities of clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of …

Medable Announces its Continued Commitment to Global Privacy and Data Protection Through Earned CIPP/E Certification | Business Wire | 1/11/2020

PALO ALTO, Calif.- Medable Inc ., the end-to-end platform for digitally enabled and data-driven clinical trials, today announced that Andrea Sanchez, Vice President Legal & SaMD secured CIPP/E Certification. A member of the … capture and real-time analytics that remove the complexities of clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of …

Oncotype

New study suggests 21-gene recurrence score may help in radiation decision-making | 1/10/2020

… can identify low risk node positive patients who do not need radiation. Because randomized trials represent the gold standard in clinical research, TAILOR RT results could change the standard of cancer care. Until that data … The 21-gene recurrence score test is sold as the Oncotype DX Breast Recurrence Score and was developed by the California-based company Genomic Health, Inc. In multiple research studies, the test has been proven …

RoosterBio

Stem Cell Research Markets & Products, 2019 & 2020-2024, Featuring Competitive Analysis for 128 Global Market Participants | Globe Newswire | 1/8/2020

… speciality vendors of stem cell research products, such as FUJIFILM CDI, ReproCELL and Ncardia (who specialize in iPSC-related products), RoosterBio (who specializes in human MSC-specific products), and Corning (who specializes in Matrigel products … bioprinting, drug discovery, toxicology testing, and more. Of interest to clinical researchers is the potential to use stem cells within regenerative medicine, and the pharmaceutical industry is integrating stem cells to conduct pharmacological testing on …

IMS Health

coryhayward20: IQVIA, some time ago Quintiles and IMS Health, Inc. is an American worldwide … http://scoophot.com/blog/601100d6-5713-44dc-be13-bdb52c89e166 | 1/7/2020

IQVIA, some time ago Quintiles and IMS Health, Inc. is an American worldwide organization serving the joined businesses of clinical research and health information technology. It is a supplier of biopharmaceutical advancement and business re-appropriating administrations, concentrated principally on Phase I-IV clinical preliminaries and related lab and systematic administrations, including counseling administrations. It has a system of in excess of 58,000 representatives in more than 100 countries. As …

Main Suppliers and Importers of Pharmaceutical Products in Germany | 1/7/2020

… rate of the pharmaceutical products manufactured by the Germany’s drug market continued with a 2-digit growth. And according the IMS Health, the online stores earned a 12% of the German OTC drug market from … Ecron Acunova – Frankfurt, Germany; has a business of working on clinical research. EKF Diagnostics – Magdeburg, Germany; has a business of working on various diagnostics. ElexoPharm – Saarbrucken, Germany; has a business of working and researching on …

Datavant

Global Contract Regulatory Affairs Management Market Outlook for Medical Devices (2019-2030): by Types of Services Offered, Device Class, Therapeutic Areas, Geographical Regions | PR Newswire | 1/3/2020

… DATA 16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS 1MED SA 4Clinics A+ Science Abbott ABIOGENESIS CLINPHARM ABX-CRO Accell Clinical Research Accredited Consultants Accutest Global Acorn Regulatory Consultancy Services Acrapack acromion aCROss Medical Activa … Device Consulting Dalia Givony , Regulatory & Clinical Consulting Databean Datapharm Australia Datavant Datavant De Groot Technical Services DEKRA devicia DH RegSys dicentra DiscGenics DKSH Marketing Services Spain dMed Donawa Lifescience Consulting Dor Pharmaceutical Services DP Clinical …

Global Contract Regulatory Affairs Management Market Outlook for Medical Devices (2019-2030): by Types of Services Offered, Device Class, Therapeutic Areas, Geographical Regions | Markets Insider | Business Insider | 1/3/2020

… DATA 16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS 1MED SA 4Clinics A+ Science Abbott ABIOGENESIS CLINPHARM ABX-CRO Accell Clinical Research Accredited Consultants Accutest Global Acorn Regulatory Consultancy Services Acrapack acromion aCROss Medical Activa … Device Consulting Dalia Givony , Regulatory & Clinical Consulting Databean Datapharm Australia Datavant Datavant De Groot Technical Services DEKRA devicia DH RegSys dicentra DiscGenics DKSH Marketing Services Spain dMed Donawa Lifescience Consulting Dor Pharmaceutical Services DP Clinical …

Maverick Ventures

JPM: Concerto HealthAI unveils $150M raise, t2 pharma data collaborations | FierceBiotech | 1/16/2020

… characteristics of a patient population. The $150 million series B round was led by Declaration Partners with additional backing from Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. The proceeds will be slated for Concerto’s innovation … revenue gains. “Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes.” RELATED: ASCO—Concerto HealthAI uses real-world data to fill the research gap among patients excluded …

Concerto HealthAI Raises $150 Million in Series B Funding | 1/16/2020

… clinical research, accelerate breakthrough therapies, and improve patient outcomes Boston, MA – January 13, 2020 – Concerto HealthAI, the market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today it has raised $150 million in aggregate Series B financing. The round of financing was led by Declaration Partners with participation from Maverick Ventures, AllianceBernstein PCI, and SymphonyAI Group. As part of the transaction, Andrew Goldfarb …

Frazier Healthcare Partners

40 GI company developments in 2019 | Becker’s ASC Review | 12/23/2019

… Duodenoscope, marking the first time the agency approved a single-use duodenoscope. TKS 1 made an investment in gastrointestinal-focused clinical research company Objective GI. Advanced Medical Solutions Group acquired surgical sealant company Sealantis. Bloomington … intent to acquire competitor Allergan for $63 billion. Takeda and Frazier Healthcare Partners launched Phathom Pharmaceuticals to develop gastrointestinal treatments. A late-stage study for Gilead Science’s drug to treat fibrosis symptoms associated with nonalcoholic …

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… corporate executive with a successful track record in pharmaceutical research and development. He is currently Entrepreneur in Residence (EIR) at Frazier Healthcare Partners in Palo Alto, CA. This followed a 14-year career at Takeda … as nurturing culture. Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation and was responsible for leading all Global Clinical R&D Operations functions in support of Celgene sponsored trials …

Goldman Sachs

PRA Health Sciences Inc (NASDAQ:PRAH) Given Average Rating of “Buy” by Analysts - Dakota Financial News | 12/4/2019

… Sciences from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, September 4th. Goldman Sachs Group started coverage on PRA Health Sciences in a research note on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Voya Investment Management LLC Boosts Stock Holdings in PRA Health Sciences Inc (NASDAQ:PRAH) | 12/3/2019

… hold” rating and set a $108.00 price target for the company. in a research report on Tuesday, November 5th. Finally, Goldman Sachs Group initiated coverage on PRA Health Sciences in a research report on Thursday … and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations …

Morgan Stanley

Huami Corporation Announced Corporate Mission: Connect Health with Technology | PR Newswire | 12/4/2019

… functionality such as step counting and sleep monitoring, to the cutting-edge AI chip Huangshan-1. According to a recent Morgan Stanley research report, the global health care market was estimated to be six times … the Mayo Clinic and Cleveland Clinic are conducting extensive cooperative clinical research, algorithm development, and AI data training. This collaboration will explore the opportunity to deliver new high-performance ECG form factors to global markets …

First Analysis

Cognition at age 70: Life course predictors and associations with brain pathologies | 12/2/2019

… and head size, TIV was included in all models, as were the demographic and life course factors investigated in the first analysis (sex, age at assessment, childhood cognitive ability, education, and adult SEP). Interactions were … the manuscript. T. Parker is supported by a Wellcome Trust Clinical Research Fellowship (200109/Z/15/Z). C. Lane reports no disclosures relevant to the manuscript. A. Keshavan is supported by a Clinical Research Fellowship …

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting | PR Newswire | 11/21/2019

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting - AbbVie will present more than 40 abstracts featuring data from approved and investigational medicines … 7:00 a.m. – 8:30 a.m. ET Oral Presentation: 8:15 a.m. ET First Analysis from a Phase 1/2 Study of Venetoclaxin Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma Oral Session: 6:15 …

Third Rock Ventures

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma [Research Articles] | 12/2/2019

… has ownership interest (including patents) in ISO. C. Lengauer is Executive Vice President at Blueprint Medicines, is a partner at Third Rock Ventures, is a director at Hookipa, is a scientific advisory board member for … the UCL Experimental Cancer Medicine Centre and the NIHR UCLH Clinical Research Facility and Biomedical Research Centre. This study was funded by Blueprint Medicines . Footnotes Note: Supplementary data for this article are available at Cancer …

Targeting the Inner Ear | 10/29/2019

… to Otonomy’s, though a different approach, according to COO Paula Cobb. It started with one of the partners at Third Rock Ventures dealing with tinnitus. He asked, “Why are there no medicines for … thing, I think it is really important to do the clinical research,” he says. “I think the biggest disservice that we can do to the field is to project unrealistic expectations,â …

NovaQuest

NovaQuest Capital Closes $275 Million For Private Equity Fund | 11/28/2019

Healthcare and life sciences focused private investment firm NovaQuest Capital Management has closed $275 million in total capital commitments for Fund I NovaQuest Capital Management — a healthcare and life sciences focused private investment firm — announced … Clinical Ink (provider of eClinical services and technologies), and Catalyst Clinical Research (provider of outsourced clinical services for clinical trials) NovaQuest Private Equity targets growth-oriented opportunities to reduce the total cost of care, meet …

NovaQuest Capital Management Closes Latest Fund, at $275M | 11/22/2019

By FinSMEs NovaQuest Capital Management, L.L.C , a Raleigh, NC-based healthcare and life sciences focused private investment firm, closed NovaQuest Private Equity Fund I, L.P., at $275m. Fund I received support from a global investor … and technologies, including eSource, ePRO, eCOA, among others; and Catalyst Clinical Research, a provider of outsourced clinical services for clinical trials. Co-founded by Dennis Gillings, Ph.D, CBE and Ron Wooten, NovaQuest Capital Management currently …

Bridge Bank

Caliber Imaging & Diagnostics, Inc. Secures $5.0 Million in Debt Financing from Bridge Bank concurrent with $1.5 Million Equity Financing | BioSpace | 11/27/2019

Caliber Imaging & Diagnostics, Inc. Secures $5.0 Million in Debt Financing from Bridge Bank concurrent with $1.5 Million Equity Financing Published: Nov 26, 2019 BOSTON, Nov. 26, 2019 /PRNewswire/ – Caliber Imaging & Diagnostics , Inc. (Caliber I.D.) a … and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries. Headquartered in Andover, Massachusetts, Caliber I.D. has more than 20 years of experience specializing in confocal microscopy. Caliber I.D …

Bridge Bank Provides $5MM Term Loan to Caliber Imaging | 11/27/2019

Bridge Bank Provides $5MM Term Loan to Caliber Imaging Caliber Imaging & Diagnostics closed a $5 million term loan financing from Bridge Bank . The first $3 million tranche will be funded upon closing and the remaining … and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries …

Maxim Group

Caliber Imaging & Diagnostics, Inc. Secures $5.0 Million in Debt Financing from Bridge Bank concurrent with $1.5 Million Equity Financing | BioSpace | 11/27/2019

… million in equity financing in a private placement with existing shareholders. “The Caliber team was pleased to work with the Maxim Group to find a partner like Bridge Bank. The proceeds from these financings will … and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries. Headquartered in Andover, Massachusetts, Caliber I.D. has more than 20 years of experience specializing in confocal microscopy. Caliber I.D …

Bridge Bank Provides $5MM Term Loan to Caliber Imaging | 11/27/2019

Maxim Group to find a partner like Bridge Bank. The proceeds from these financings will enable us to execute upon our strategic growth plan,” said Mike Hone CEO of Caliber I.D. Andover, MA-based Caliber Imaging & Diagnostics designs and manufactures in-vivo and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries …

JP Morgan

Knowledge Process Outsourcing (KPO) Market To Reflect Impressive Expansion Due To Tremendous Growth In Healthcare, BFSI, And Retail Sector Till 2025 | Million Insights | 11/27/2019

… outsourcing for knowledge intensive services. Bio-tech and pharmaceutical are the sub industries of healthcare segment for drug discovery and clinical research. Types of services carried out by KPO include consultancy, research and development, legal … Ford, United Airlines, Morgan Stanley, Reuters, Goldman Sachs, McKinsey, Citigroup, JP Morgan, Motorola, Philips, Sun Microsystems, Texas Instruments, Cisco, Oracle, Intel, Microsoft, HP, IBM, and GE. In the pharmaceutical industry, global pharmaceutical firms such as …

Knowledge Process Outsourcing (KPO) Market To Reflect Impressive Expansion Due To Tremendous Growth In Healthcare, BFSI, And Retail Sector Till 2025 | Million Insights | The Wapakoneta Daily News | 11/27/2019

… outsourcing for knowledge intensive services. Bio-tech and pharmaceutical are the sub industries of healthcare segment for drug discovery and clinical research. Types of services carried out by KPO include consultancy, research and development, legal … Ford, United Airlines, Morgan Stanley, Reuters, Goldman Sachs, McKinsey, Citigroup, JP Morgan, Motorola, Philips, Sun Microsystems, Texas Instruments, Cisco, Oracle, Intel, Microsoft, HP, IBM, and GE. In the pharmaceutical industry, global pharmaceutical firms such as …

Tufts Medical Center

mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease | Nature | 1/17/2020

… latency of 144.2 min. Such late-batch participants and highly non-adherent participants are often the subject of anecdotes by clinical researchers employing motor diaries. In the context of studies utilizing paper versions, it may … out at the clinical and translational research center (CTRC) at Tufts Medical Center. Written informed consent was obtained from all participants, all relevant ethical regulations were complied with, and the protocol was approved by the …

Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging: Page 3 of 3 | Modern Retina | 1/7/2020

Tufts Medical Center and Tufts University School of Medicine, Boston; • K. Bailey Freund, MD, clinical professor of ophthalmology, New York University School of Medicine, and in practice with Vitreous Retina Macula Consultants of New York; • Szilard Kiss, MD, director of clinical research, Department of Ophthalmology, Weill Cornell Medical College; • Giuseppe Querques, MD, associate professor, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy; • David Sarraf, MD, full-time faculty member …

Mercy Health

Bon Secours Mercy Health invests in Lirio artificial intelligence platform | Healthcare IT News | 1/17/2020

… developer of behavior change technology at the J.P. Morgan Healthcare Conference this week. January 17, 2020 11:00 AM Bon Secours Mercy Health has signed an agreement with Tennessee-based behavior change startup Lirio, making a … decisions and take healthy actions,” said Dr. Justin McGoldrick, chief clinical research and innovation officer at Bon Secours Mercy Health, in a statement …

Bon Secours Mercy Health and Lirio Announce Partnership and Investment | PR Newswire | 1/16/2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment Health system and Artificial Intelligence leader collaborate to drive positive behavior change News provided by Jan 15, 2020, 18:22 ET Share this article CINCINNATI and … decisions and take healthy actions,” said Justin McGoldrick , M.D., chief clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health …

Bon Secours Mercy Health

Bon Secours Mercy Health invests in Lirio artificial intelligence platform | Healthcare IT News | 1/17/2020

… with the developer of behavior change technology at the J.P. Morgan Healthcare Conference this week. January 17, 2020 11:00 AM Bon Secours Mercy Health has signed an agreement with Tennessee-based behavior change startup Lirio … decisions and take healthy actions,” said Dr. Justin McGoldrick, chief clinical research and innovation officer at Bon Secours Mercy Health, in a statement …

Bon Secours Mercy Health and Lirio Announce Partnership and Investment | PR Newswire | 1/16/2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment Health system and Artificial Intelligence leader collaborate to drive positive behavior change News provided by Jan 15, 2020, 18:22 ET Share this article CINCINNATI and … decisions and take healthy actions,” said Justin McGoldrick , M.D., chief clinical research and innovation officer at Bon Secours Mercy Health. “This will be central to our health system’s enhanced ability to improve the overall health …

NYU Langone Health

New use for an old drug: The potential of colchicine in CVD | 1/16/2020

… Women’s Hospital and Eugene Braunwald Professor of Medicine at Harvard Medical School, told Cardiology Today. Binita Shah, MD, MS, from NYU Langone Health, said colchicine appears to reduce vascular inflammation, but more research is needed … by a VA Career Development Award and an AHA Mentored Clinical Research Award, and the drug was supplied by Takeda Pharmaceuticals and the Manhattan VA Hospital Research Pharmacy. Jolly, Libby, Lloyd-Jones and Mandell report …

Multiple Sclerosis (MS) | 1/13/2020

… lower risk of MS. Further research is needed to confirm whether omega-3 fats are protective against MS and future clinical research should also determine whether supplementation in patients with MS is helpful for reducing … Current Stimulation (tDCS) Leigh Carbet, PhD, a clinical neuropsychologist at NYU Langone Health, is leading a pilot study to determine whether transcranial direct current stimulation (tDCS) can improve fine motor function in people with progressive …

MedStar Health

‘Everything we do should be about the patient,’ says Piedmont heart surgeon Vinod Thourani | Becker’s Hospital Review | 1/11/2020

… MedStar Health, co-director of Emory Healthcare’s Structural Heart and Valve Center and chief of cardiothoracic surgery at Emory University Hospital Midtown. Most recently, Dr. Thourani joined Piedmont Heart Institute in October as the Marcus chief of cardiovascular surgery for Piedmont Healthcare and the Marcus Heart Valve Center. Becker’s Hospital Review recently caught up with Dr. Thourani to discuss his clinical research, training and advice for other physicians. Editor’s note …

Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice | 12/30/2019

… MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi is also an NCI recognized consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey. The consortium reflects an integrated cancer research enterprise with scientists and physician-researchers from both locations. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational and clinical research, patient care, community education and outreach to service …

Leiden University Medical Center

Vitalis Plans to Launch Phase 3 Trial Testing VTS-72 as Treatment for RRMS-related Flushing | 1/10/2020

… clinical research. Fact Checked By: Patricia Silva, PhD Total Posts: 1,053 Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and …

Review Recommends International Consensus be Reached on What Constitutes PH in Newborns | 1/8/2020

… defining severity of disease,” they added. Author Details Joana Carvalho, MSc Joana is currently completing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. She also holds a BSc in Biology and an … her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto …

Emory Healthcare

Verily taps Tesla CFO as it looks innovate in value-based care | FierceBiotech | 1/10/2020

… many: better, less expensive care for many people.” Last month, Verily announced separate partnerships with Wake Forest Baptist Health and Emory Healthcare focused on using tech solutions to boost patient outcomes, operational efficiencies and the … believed that if we connected the world of sensors and clinical research with sophisticated computing infrastructure and activated those insights for people with user-friendly platforms, we could improve outcomes and move value-based care …

36 hospitals, health systems that partnered with big tech in 2019 | Becker’s Hospital Review | 12/28/2019

… implement IBM Watson Health Imaging’s Patient Synopsis radiology AI software. 6. Verily launched the Baseline Health System Consortium to make clinical research more accessible for patients, clinicians and researchers. The consortium’s six initial members are … the health and wellness of senior citizens living independently. 17. Emory Healthcare in Atlanta partnered with Verily to use advanced data analytics to improve cost-effectiveness, efficiency and quality. Additionally, many of these health-tech …

Perlmutter Cancer Center

Merck’s Keytruda Gets FDA Approval for High-Risk Bladder Cancer | Equities News | 1/10/2020

… for these patients. - Arjun V. Balar, MD, associate professor of Medicine and director of Genitourinary Medical Oncology, NYU Langone Health’s Perlmutter Cancer Center. That’s the third bladder cancer indication for which Merck has received approval … limited FDA-approved therapies available. -Scot Ebbinghaus, MD, vice president, clinical research, Merck Research Laboratories. While some analysts have voiced concern about the growth trajectory of Merck’s wonder drug, Barron’s reported in October 2019 that …

Merck’s Keytruda Approved for High-Risk Bladder Cancer | BioSpace | 1/9/2020

… expanding existing treatment options for certain patients with high-risk, non-muscle invasive bladder cancer,” said Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. Ebbinghaus added, “As the first anti-PD-1 therapy approved … and director of Genitourinary Medical Oncology at NYU Langone Health’s Perlmutter Cancer Center. “Historically, patients with high-risk, non-muscle invasive bladder cancer with CIS whose cancer is unresponsive to BCG treatment had limited non …

Geisinger

EMBASE Cardiac Update AutoAlert: EPICORE Cardiac Surgery Blogger2 | 12/29/2019

… of available-evidence”-based prevention of perioperative adverse events in children with SCD, and highlight the most urgent priorities in clinical research. As data sources, US National Library of Medicine, Medline, National Guideline Clearinghouse, International … United States (Croce) Brigham and Women’s Hospital, United States (Skelding) Geisinger Medical Center, United States (Patel) St Joseph Mercy Oakland, United States (Garratt, Papadakos) Lenox Hill Hospital, United States (Harjai) Donald Guthrie Foundation, United States …

36 hospitals, health systems that partnered with big tech in 2019 | Becker’s Hospital Review | 12/28/2019

… implement IBM Watson Health Imaging’s Patient Synopsis radiology AI software. 6. Verily launched the Baseline Health System Consortium to make clinical research more accessible for patients, clinicians and researchers. The consortium’s six initial members are … data analytics and machine learning technologies. 13. Danville, Pa.-based Geisinger Health System announced a collaboration with the IBM Data Science and AI Elite teams to develop predictive AI-based sepsis prevention tools. 14. Verily …

Inova Health System

36 hospitals, health systems that partnered with big tech in 2019 | Becker’s Hospital Review | 12/28/2019

… implement IBM Watson Health Imaging’s Patient Synopsis radiology AI software. 6. Verily launched the Baseline Health System Consortium to make clinical research more accessible for patients, clinicians and researchers. The consortium’s six initial members are … partnership with several healthcare organizations, including Falls Church, Va.-based Inova Health System . 8. Rush University Medical Center in Chicago migrated to the Google Cloud platform to expand access to patients’ unstructured health data. 9 …

(USA-VA-FALLS CHURCH) CLINICAL RESEARCH NURSE | 11/25/2019

Inova Health Systems CLINICAL RESEARCH NURSE in FALLS CHURCH , Virginia Job Description ADVANCED LUNG DISEASE RESEARCH Adheres to ICH- GCP, DHHS( OHRP and FDA), and Inova Health System guidelines when implementing research trials to ensure highest quality research within Inova Health System from site selection to study closure. Financial Management/Research Billing: Coordinates financial aspects of clinical trial implementation from protocol feasibility through to study closure. Quality Assurance/Regulatory Compliance …

Health Net

Invitae (NYSE:NVTA) 2019 financial results: 70% growth in accounts, 60% growth in test volume, 45% growth in revenue year-over-year | 1/13/2020

… variant interpretation capabilities, meaningfully reduce the cost of testing and provide superior customer workflows and patient support. Presented and published clinical research demonstrating the frequency of actionable genetic variants in large patient populations and supporting … United States and internationally: Partnered with the University of Vermont Health Network on a population health testing program to offer proactive genetic screening as part of routine clinical care for patients in Vermont. Announced in …

Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year | PR Newswire | 1/12/2020

… variant interpretation capabilities, meaningfully reduce the cost of testing and provide superior customer workflows and patient support. Presented and published clinical research demonstrating the frequency of actionable genetic variants in large patient populations and supporting … United States and internationally: Partnered with the University of Vermont Health Network on a population health testing program to offer proactive genetic screening as part of routine clinical care for patients in Vermont . Announced in …

Aetna

Calculating the Costs of Clinical Trials | 12/1/2019

… have to worry about costs could make a big difference.” At the NIH Clinical Center, a hospital devoted entirely to clinical research, the costs of participating in a clinical trial are completely covered, Dr. Millum … and established standards of care for a particular diagnosis.” 5 Aetna’s website stipulates that “all applicable plan limitations for coverage of out-of-network care will apply to routine care costs in clinical trials.” 6 …

Indian Health Service

TelAbortion could ease access woes - New Mexico Political Report | 11/26/2019

… health provider’s time, the medication and a follow up via video, said Ann Firstenberg, Planned Parenthood of the Rocky Mountains’ clinical research coordinator. Planned Parenthood of the Rocky Mountains is the organization offering the study … Amendment, Native Americans cannot get an abortion at their local Indian Health Services clinic. The Hyde Amendment places restrictions on federal dollars paying for abortion except in the event of rape, incest or if the …

Harvard Pilgrim Health Care

Evaluation of the impact of calorie labeling on McDonald’s restaurant menus: a natural experiment | 11/4/2019

… from April through June in each year of data collection. This study was approved by the institutional review board of Harvard Pilgrim Health Care. Participant enrollment We invited all adults (≥18 years), adolescents (11–20 … content at fast food restaurants: cross sectional observational study. BMJ (Clinical research ed). 2013;346:f2907. Google Scholar 3. Franckle RL, Block JP, Roberto CA. Calorie underestimation when buying high-calorie beverages in fast-food …

Understanding childhood obesity in the US: the NIH environmental influences on child health outcomes (ECHO) program | Nature | 10/24/2019

… Diane J. Catellier Division of Chronic Disease Research Across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA Emily Oken Department of Epidemiology, Johns Hopkins … Andrea E. Cassidy-Bushrow Welch Center for Epidemiology, Prevention and Clinical Research, Johns Hopkins University Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Noel T. Mueller Department of Public Health …

Melinda Gates

Environment change research study focuses on African females farmers – CSMonitor.com | 1/18/2020

… lens to help African smallholders adapt to environment shifts, unusually offering Africans the opportunity to serve as mentors.Underinvestment in African clinical research capability means”we still don’t even know the specific ways environment change will … on the initiative, worth nearly$ 20 million, with the Bill & Melinda Gates Foundation, France’s BNP Paribas Structure, Agropolis Fondation, the European Union, and Canada’s International Development Research Centre.Firsthand experience As one of the inaugural fellows …

Life Science Washington Welcomes New Board Chair, Executive Committee Members, and Directors | Business Wire | 1/13/2020

Melinda Gates Foundation Leen Kawas, PharmD & PhD, President & CEO, Athira Pharma, Inc. Jary J. Krauser, CEO, StratusG Consulting Tim Martin, Director, United States Government Affairs, Amgen Sean McClain, Founder & CEO, AbSci Claudia Mitchell, PhD, MBA, Senior VP, Product and Portfolio Strategy, Astellas Erik Nilsson, CEO, Deurion, LLC Jennifer Olsen, CEO, Resourceful HR Robert W. Overell, PhD, President, Foundation BioVentures Mitchell Parrish, JD, RAC, CIP, President, PanAmerican Clinical Research Craig Philips …

Seth Rogen

Canopy Growth Revises Beverage Launch Timeline | PR Newswire | 1/17/2020

… dozen countries across five continents. Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars … with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates …

Gavin Newsom

Kaiser Permanente Pledges $25M to Governor’s California Housing Fund | PR Newswire | 1/17/2020

… 17, Nonprofit health care system Kaiser Permanente today announced it will be a first private sector contributor to California Governor Gavin Newsom’s newly announced fund to combat homelessness in the state, committing $25 million to … chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. https://about.kaiserpermanente.org/ For more information, contact: Marc Brown , [email protected] , 510-271-6328 SOURCE Kaiser Permanente Related …

$25M pledge to California governor’s housing fund | 1/17/2020

… and Services Fund, extending its work toward solving homelessness. Kaiser Permanente Chairman and CEO Greg Adams meets with California Governor Gavin Newsom to discuss the California Access to Housing and Services Fund. Kaiser Permanente is … chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health …

Jeff Elton

JPM: Concerto HealthAI unveils $150M raise, t2 pharma data collaborations | FierceBiotech | 1/16/2020

… the company’s board—referring to its 90% year-over-year revenue gains. “Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes.” RELATED: ASCO—Concerto HealthAI uses real … scientists to optimize drug development for patients,” said Concerto CEO Jeff Elton

Concerto HealthAI Raises $150 Million in Series B Funding | 1/16/2020

… Ref: Concerto HealthAI) Developer of Real-World Data and enterprise AI technology for Precision Oncology Funding will power next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes Boston, MA – January 13, 2020 – Concerto … CEO of SymphonyAI Group, will continue as executive chairman, and Jeff Elton, PhD, CEO of Concerto HealthAI as board member. Click to Tweet : @ConcertoHealthAI CEO Jeff Elton speaks at JPM in San Francisco Jan 13 …

Fred Hutchinson

Gamma Secretase Inhibitor Improves Responses to BCMA CAR T Cells in Myeloma | 1/15/2020

Clinical Research Division, Fred Hutchinson Cancer Research Center. According to a presentation at the 2019 American Society of Hematology (ASH) Annual Meeting, a phase I clinical trial (NCT03502577) is evaluating the combination of a gamma-secretase inhibitor (GSI) therapy with BCMA CAR T cells to improve response in heavily pretreated patients. BCMA is widely expressed on the surface of plasma cells in patients with multiple myeloma, which makes it a …

New study suggests 21-gene recurrence score may help in radiation decision-making | 1/10/2020

… can identify low risk node positive patients who do not need radiation. Because randomized trials represent the gold standard in clinical research, TAILOR RT results could change the standard of cancer care. Until that data … PhD, of the SWOG Statistics and Data Management Center at Fred Hutchinson Cancer Research Center; Reshma Jagsi, MD, of University of Michigan; Thomas A. Bucholz, MD, of the University of Texas MD Anderson Cancer Center …

Anthony Fauci

NIAID Council Minutes: September 9, 2019 | National Institutes of Health | 1/15/2020

… Diseases (DMID), and NIAID associate director for biodefense product development. Dr. Sophia Siddiqui has been detailed from the Division of Clinical Research to the Office of the Secretary, Office of Global Affairs, where she will … American Association of Immunologists Distinguished Fellows Class of 2019–Drs. Anthony Fauci, Ron Germain, Susan Pierce, and Ethan Shevach. Dr. Holland presented details about a new joint initiative between NIAID, the National Cancer Institute, and …

Ebola patient treated in the U.S. shares his story | 1/2/2020

… Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and one of Gorman’s many doctors. One by one, Gorman’s organs began to fail. His kidneys, his liver, his heart and his lungs were overwhelmed, his immune system unable to stop the virus, said Richard Davey, chief of NIAID’s clinical research section and Gorman’s lead physician. Gorman also developed brain inflammation. With Ebola spreading across West Africa, an …

Alex Azar

NIAID Council Minutes: September 9, 2019 | National Institutes of Health | 1/15/2020

… Diseases (DMID), and NIAID associate director for biodefense product development. Dr. Sophia Siddiqui has been detailed from the Division of Clinical Research to the Office of the Secretary, Office of Global Affairs, where she will … as the etiologic agent in AFM. In June, HHS Secretary Alex Azar and Department leaders attended a meeting at NIH to discuss how to implement the plan for ending the HIV/AIDS epidemic. NIH has …

JPM health conference kicks off - POLITICO | 1/13/2020

… raises addiction risks for children. — The Trump administration is focusing on anti-human trafficking initiatives this month , with HHS Secretary Alex Azar and other top officials visiting Atlanta on Tuesday. WELCOME BACK TO MONDAY PULSE … but it’s a shame to keep equating modern forms of clinical research with a lower standard,” tweeted Robert Califf, a former FDA commissioner during the Obama administration. TUESDAY: AZAR IN ATLANTA FOR ANTI-TRAFFICKING SITE …

Walid Abi-Saab

Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis Brussels Stock Exchange:GLPG | Globe Newswire | 1/13/2020

… PINTA trial, with recruitment completed ahead of schedule, and look forward to learning more about GLPG1205 in IPF,” said Dr. Walid Abi-Saab, Chief Medical Officer at Galapagos. “We are strongly committed to the rapid … and there is growing evidence in scientific literature and in clinical research that GPR84 plays a role in this disease. GLPG1205 successfully completed several Phase 1 trials, showing favorable findings relating to tolerability and target …

Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis | The Wapakoneta Daily News | 1/13/2020

… PINTA trial, with recruitment completed ahead of schedule, and look forward to learning more about GLPG1205 in IPF,” said Dr. Walid Abi-Saab, Chief Medical Officer at Galapagos. “We are strongly committed to the rapid … and there is growing evidence in scientific literature and in clinical research that GPR84 plays a role in this disease. GLPG1205 successfully completed several Phase 1 trials, showing favorable findings relating to tolerability and target …

Pete Buttigieg

JPM health conference kicks off - POLITICO | 1/13/2020

… to back off real-world evidence . “Some good ideas here, but it’s a shame to keep equating modern forms of clinical research with a lower standard,” tweeted Robert Califf, a former FDA commissioner during the … a public option, as moderate candidates like Joe Biden and Pete Buttigieg surged. Now, as Sen. Bernie Sanders (I-Vt.) gains ground in Iowa, The Partnership is pivoting back to warnings about his signature health …

Sunburn — The morning read of what’s hot in Florida politics — 12.13.19 | 12/13/2019

… it running, the lawmaker announced. Smith is also introducing legislation requesting $1,050,000 to expand the work of UCF RESTORES — a clinical research and treatment facility at the University of Central Florida that provides therapy to … Booker , Amy Klobuchar and Elizabeth Warren , as well as Mayor Pete Buttigieg and former Massachusetts Gov. Deval Patrick , according to the Florida Democratic Party “ Amy Klobuchar set to meet with union leaders in South Florida …

Scot Ebbinghaus

Merck’s Keytruda immunotherapy FDA-approved to treat high-risk bladder cancer | Becker’s Hospital Review | 1/10/2020

Merck’s Keytruda immunotherapy FDA-approved to treat high-risk bladder cancer Maia Anderson - Print Email Merck’s immunotherapy drug, Keytruda, was approved as a monotherapy to treat patients with a type of high-risk bladder cancer, the drugmaker announced Jan. 8. The type of bladder cancer previously had limited FDA-approved therapies available to treat it, according to Scot Ebbinghaus, MD, vice president of clinical research at Merck. Patients traditionally have …

Merck’s Keytruda Gets FDA Approval for High-Risk Bladder Cancer | Equities News | 1/10/2020

… Scot Ebbinghaus, MD, vice president, clinical research, Merck Research Laboratories. While some analysts have voiced concern about the growth trajectory of Merck’s wonder drug, Barron’s reported in October 2019 that research firm GlobalData believes KEYTRUDA will be the world’s best-selling drug by 2023, with annual sales projected to hit $22.2 billion by 2025. Edward Kim is Managing Editor of Equities.com …